Johnson & Johnson (JNJ) Change in Inventory (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Change in Inventory came in at $431.0 million in Q1 2026, up 195.21% year-on-year from $146.0 million in Q1 2025, and up 836.96% quarter-over-quarter from $46.0 million in Q4 2025.

Johnson & Johnson (JNJ) Change in Inventory (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Change in Inventory across 18 years of filings, most recently posting $431.0 million for Q1 2026.

  • Change in Inventory for Q1 2026 came in at $431.0 million, up 195.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 billion (up 87.37% YoY), and the FY2025 annual result was $1.5 billion, up 28.55% from the prior year.
  • Change in Inventory came in at $431.0 million for Q1 2026 at Johnson & Johnson, up from $46.0 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $1.3 billion in Q1 2023 to a low of -$124.0 million in Q4 2023.
  • The 5-year median for Change in Inventory is $391.0 million (2024), against an average of $418.7 million.
  • Across the five-year window, Change in Inventory tumbled 109.19% in 2023 and surged 195.21% in 2026, its largest moves.
  • Johnson & Johnson's Change in Inventory stood at $600.0 million in 2022, then plunged by 120.67% to -$124.0 million in 2023, then jumped by 172.58% to $90.0 million in 2024, then plunged by 48.89% to $46.0 million in 2025, then jumped by 836.96% to $431.0 million in 2026.
  • The last three Change in Inventory figures came in at $431.0 million (Q1 2026), $46.0 million (Q4 2025), and $748.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn -
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn -
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 431.00 Mn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 184.00 Mn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn -
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn -18.00 Mn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 52.00 Mn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn -
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn -14.00 Mn
10 Novartis Ag 108.28 Bn 107.60 Bn - -95.00 Mn

Historic Data

Download Data
DateValue
Mar 29, 2026 431.00 Mn
Mar 29, 2026 431.00 Mn
Dec 28, 2025 46.00 Mn
Dec 28, 2025 46.00 Mn
Sep 28, 2025 748.00 Mn
Sep 28, 2025 748.00 Mn
Jun 29, 2025 510.00 Mn
Jun 29, 2025 510.00 Mn
Mar 30, 2025 146.00 Mn
Mar 30, 2025 146.00 Mn
Dec 29, 2024 90.00 Mn
Dec 29, 2024 90.00 Mn
Sep 29, 2024 299.00 Mn
Sep 29, 2024 299.00 Mn
Jun 30, 2024 391.00 Mn
Jun 30, 2024 391.00 Mn
Mar 31, 2024 348.00 Mn
Mar 31, 2024 348.00 Mn
Dec 31, 2023 -124.00 Mn
Dec 31, 2023 -124.00 Mn